News & Press Releases
2024-09-17
Medunik USA expands Medicaid coverage and patient support services for Pheburane® (sodium phenylbutyrate)
2024-06-04
Medunik USA’s UNIK Support Program for Pheburane® expands to now include 2 specialty pharmacy options
2024-01-19
Pheburane® (sodium phenylbutyrate) is now on the Medicaid Preferred Drug List in 10 states
2023-10-26
Pheburane® (sodium phenylbutyrate) coverage to reach ~80% of commercially insured US patients by January 1st, 2024
2023-09-25
In honor of National Sickle Cell Awareness Month, Tanya Carro, Executive Vice President of Medunik USA, speaks about the sickle cell disease community
2023-09-21
Important SCA treatment option is now covered by Medicaid programs in 19 states
2023-08-09
Pheburane® (sodium phenylbutyrate) coverage rapidly expands to the benefit of Americans with certain urea cycle disorders (UCDs)
2023-05-17
Pheburane® Expanded Coverage with Commercial and Government (Medicaid) Payers
2022-09-06
Medunik USA launches Pheburane® (sodium phenylbutyrate) oral pellets, a unique, taste-masked formulation of sodium phenylbutyrate (NaPB) used along with a specific diet for the long-term management of certain urea cycle disorders
2022-02-16
Hydroxyurea-based treatment for sickle cell anemia previously available for pediatric patients now approved for use in adults
2021-11-10
Senior management team takes over ownership of Quebec-based multinational pharmaceutical group Duchesnay
2020-10-19
The first and only hydroxyurea-based treatment for pediatric patients with sickle cell anemia, now available in 100 mg scored tablets to help further optimize dosing
2020-06-22
Dr. Corey Hebert hosts a four-part video series on “What you need to know about sickle cell anemia”
2019-06-19
On World Sickle Cell Day, Medunik USA highlights the importance of early treatment of Sickle Cell Disease
2019-04-09
Medunik USA expands access to the first and only prescription medication for pediatric sickle cell anemia patients by offering 340B pricing to covered entities through Apexus.
2019-03-12
Medunik USA announces two savings programs that allow families affected by sickle cell disease to pay as little as $0 for their child’s prescription
2018-11-13
The first and only prescription medication for pediatric patients with sickle cell anemia, now available in 1,000 mg triple-scored tablets to help optimize dosing
2018-09-12
The only prescription medication for pediatric patients with sickle cell anemia, is now available through our ProCare Pharmacy Care's program
2018-08-21
Now available in retail pharmacies, the first and only prescription medication for pediatric patients with sickle cell anemia